Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026850 (
muscular dystrophy
)
5,870
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The Ser/Thr protein kinase
ULK1
is an upstream macroautophagy/autophagy regulator that is rapidly activated to ensure a proper adaptive response to stress conditions. Signaling pathways modulating
ULK1
activity have been extensively characterized in response to nutrient/energy shortage, which mainly act by mediating
ULK1
post-translational modifications, such as phosphorylation, acetylation and ubiquitination. Less characterized is how tissue-specific stress signals are able to activate
ULK1
to induce autophagy. Our recent study has uncovered the E3 ubiquitin ligase TRIM32 as a novel
ULK1
activator that regulates autophagy in muscle cells upon atrophy induction. TRIM32 is conveyed to
ULK1
by the autophagy cofactor AMBRA1 to stimulate its kinase activity through unanchored K63-linked polyubiquitin chains. Notably, mutations in TRIM32 responsible for limb-girdle muscular dystrophy 2H disrupt its ability to bind
ULK1
and to induce autophagy in muscle cells, resulting in a dysregulated activation of the atrophic process. In conclusion, we have identified a novel molecular mechanism by which autophagy is regulated in muscles, whose alteration is associated with the development of
muscular dystrophy
.
...
PMID:A TRIM32-AMBRA1-ULK1 complex initiates the autophagy response in atrophic muscle cells. 3112 3